Legal & General Group Plc cut its position in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 1.4% during the first quarter, Holdings Channel reports. The institutional investor owned 3,756 shares of the company’s stock after selling 54 shares during the period. Legal & General Group Plc’s holdings in USANA Health Sciences were worth $217,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in USNA. Karp Capital Management Corp bought a new stake in USANA Health Sciences during the first quarter worth about $595,000. Ramsey Quantitative Systems acquired a new position in USANA Health Sciences during the first quarter worth approximately $507,000. HPM Partners LLC acquired a new position in USANA Health Sciences during the first quarter worth approximately $268,000. Algert Global LLC boosted its position in USANA Health Sciences by 8.4% in the first quarter. Algert Global LLC now owns 21,843 shares of the company’s stock worth $1,258,000 after buying an additional 1,685 shares during the last quarter. Finally, First Trust Advisors LP boosted its position in USANA Health Sciences by 104.3% in the first quarter. First Trust Advisors LP now owns 25,069 shares of the company’s stock worth $1,444,000 after buying an additional 12,800 shares during the last quarter. 43.90% of the stock is currently owned by institutional investors and hedge funds.

USANA Health Sciences, Inc. (NYSE USNA) traded up 1.29% during trading on Friday, reaching $58.80. The company had a trading volume of 120,279 shares. The company has a 50-day moving average price of $61.41 and a 200 day moving average price of $60.57. USANA Health Sciences, Inc. has a one year low of $52.55 and a one year high of $150.00. The company has a market capitalization of $1.44 billion, a price-to-earnings ratio of 15.27 and a beta of 1.10.

USANA Health Sciences (NYSE:USNA) last released its earnings results on Tuesday, July 25th. The company reported $0.98 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.06 by $0.08. USANA Health Sciences had a net margin of 9.47% and a return on equity of 28.93%. The company had revenue of $257.10 million for the quarter, compared to the consensus estimate of $273.61 million. During the same period in the prior year, the company earned $2.07 earnings per share. The firm’s revenue was down .5% on a year-over-year basis. Analysts expect that USANA Health Sciences, Inc. will post $3.79 earnings per share for the current year.

USANA Health Sciences declared that its board has approved a stock buyback program on Tuesday, July 25th that allows the company to repurchase $64.60 million in shares. This repurchase authorization allows the company to purchase up to 46% of its shares through open market purchases. Shares repurchase programs are often an indication that the company’s management believes its shares are undervalued.

ILLEGAL ACTIVITY WARNING: “Legal & General Group Plc Sells 54 Shares of USANA Health Sciences, Inc. (NYSE:USNA)” was first reported by Daily Political and is the sole property of of Daily Political. If you are reading this article on another site, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The correct version of this article can be viewed at https://www.dailypolitical.com/2017/08/12/legal-general-group-plc-sells-54-shares-of-usana-health-sciences-inc-nyseusna.html.

USNA has been the subject of a number of research analyst reports. Pivotal Research reiterated a “hold” rating and set a $55.00 price target (down previously from $75.00) on shares of USANA Health Sciences in a report on Monday, May 1st. BidaskClub cut USANA Health Sciences from a “hold” rating to a “sell” rating in a report on Sunday, July 16th.

In related news, Director Myron W. Wentz sold 40,000 shares of the firm’s stock in a transaction that occurred on Friday, June 2nd. The shares were sold at an average price of $64.99, for a total value of $2,599,600.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Global Ltd Gull sold 25,467 shares of the firm’s stock in a transaction that occurred on Tuesday, August 1st. The stock was sold at an average price of $56.52, for a total transaction of $1,439,394.84. Following the completion of the transaction, the insider now directly owns 12,352,753 shares of the company’s stock, valued at $698,177,599.56. The disclosure for this sale can be found here. Insiders have sold a total of 171,334 shares of company stock valued at $10,413,675 over the last three months. Insiders own 53.20% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA).

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.